A COMPARATIVE STUDY OF HOMOCYSTEINE LEVEL IN THYROID DYSFUNCTIONS BEFORE OR DURING TREATMENT. by Kamlesh Tanwani.
ISSN: 2320-5407                                                                                      Int. J. Adv. Res. 7(7), 669-670 
669 
 
Journal Homepage: -www.journalijar.com 
 
 
 
 
Article DOI:10.21474/IJAR01/ 9408 
DOI URL: http://dx.doi.org/10.21474/IJAR01/9408 
 
RESEARCH ARTICLE 
 
A COMPARATIVE STUDY OF HOMOCYSTEINE LEVEL IN THYROID DYSFUNCTIONS BEFORE 
OR DURING TREATMENT. 
 
Dr. Kamlesh Tanwani. 
…………………………………………………………………………………………………….... 
Manuscript Info   Abstract 
…………………….   ……………………………………………………………… 
Manuscript History 
Received: 20 May 2019 
Final Accepted: 22 June 2019 
Published: July 2019 
 
Key words:- 
Hypothyroid, Homocysteine, RIA, 
ELISA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction: Hyperhomocysteinemiais a disease involving abnormal 
homocysteine metabolism and is characterized by increased level of 
total homocysteine concentration (normal 5-15µmol/L). Many factors 
like dietary folate, cynocobalamine deficiency or thyroid disorders are 
the most common causes for increased homocysteine level. Thus this 
present study was planned to delineate the usefulness of levothyroxin to 
evaluate changes in homocysteine level in hypothyroid patients. 
Material And Method: The present study was conducted on 75 
patients of hypothyroidism of either sex in Department of 
Biochemistry, J.L.N. Medical College & Hospital, Ajmer. Serum 
homocysteine level was measured by ELISA while thyroid function 
tests were evaluated by RIA method. 
Result And Discussion: Before treatment serum homocysteine level 
was higher in hypothyroid patients (17.10±3.09µmol/L) as compared to 
normal subjects (8.15±n0.345µmol/l). During treatment a significant 
decrease was observed in hypothyroid patients (10.81±1.96µmol/L)  
Conclusion: It is concluded thatsupplementation of thyroxin in 
hypothyroid patients can cause significant decrease in level of 
homocysteine which can further decrease risk of coronary artery 
disorders in these patients .  
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Introduction:- 
Thyroid disorders are the most common endocrine abnormalities encountered in clinical practices. Insufficient 
thyroid hormone secretion results in hypothyroidism. The activity of MTHFR gene (gene involve in homocysteine 
metabolism) reduces in underactive thyroid and further leads to hyperhomocysteinemia in these patients. 
 
Aims & objectives:- 
To evaluate serum homocysteine levels in hypothyroid patients before treatment and during treatment (thyroxin).  
 
Material & Methods:- 
The present study conducted on 75 clinically proven hypothyroid patients of both sex in the Department of 
Biochemistry, J.L.N. Medical College, Ajmer. The selected patients were then informed about the procedure and 
written informed consent was taken. The results were compared with age matched 75 healthy control subjects of 
either sex. Following investigation were performed in all the subjects included in this study: 
1. Serum T3, Serum T4 and Serum TSH by RIA technique. 
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2. Serum homocysteine by ELISA technique 
 
Table 1:-Mean Serum homocysteine level of the subjects studied 
S.No Group studied Serum Homocysteine                                                                     
(Mean ± S.D.) 
1 Healthy Controls 8.15 ± 0.345 
2 Hypothyroid Patients (Before treatment) 17.10  ± 3.09 
3 Hyperthyroid Patients (During treatment) 10.81 ± 1.96 
 
Table 2:-Statistical analysis of Serum homocysteine among the groups studied 
 Group Compared p-value 
1 Healthy controls v/s Hypothyroids (before treatment) 0.0001 (HS) 
2 Healthy controls v/s Hypothyroids (during treatment) >0.0061 (NS) 
 
Results:- 
75 patients suffering from hypothyroidism (24 males and 51 females) and 75 healthy control subjects (24 males and 
51 females) were studied for thyroid function tests and serum homocysteine level. 
 
The mean values for serum homocysteine level was 8.15 ± 0.345 µmol/L for healthy control subjects. For 
hypothyroid patients, homocysteine levels were 17.10  ± 3.09 µmol/L and 10.81 ± 1.96µmol/L before treatment and 
during treatment respectively. 
 
Discussion & conclusion:- 
A highly significant relationship was observed in serum homocysteine levels when hypothyroid subjects (p = 
0.0001) were compared with the healthy controls before treatment. Further these patients showed a non significant 
(p> 0.0061) relationship when compared with the healthy control subjects during treatment.  
 
Before treatment, serum homocysteine level were higher in patients with hypothyroidism while during treatment a 
decrease was observed in serum homocysteine level in these patients 
 
Hypothyroidism decreases hepatic levels of enzymes involved in the remethylation pathway of homocysteine 
resulting in hyperhomocysteinemia. Supplementation of thyroxin to patients of hypothyroidism cause significant 
decrease level of serum homocysteine in these patients. 
